Weak immune system and diseases associated with Vitamin D deficiency: here are the main signs

Sistema immunitario debole e malattie associate alla carenza di Vitamina D: ecco i principali segnali

Updated and contextualized version of an article originally published on February 24, 2020
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.


Authors

  • Dr. A. Colonnese – Nutrition biologist
  • Roberto Panzironi –Independent researcher 

Note editoriali

  • First publication: February 24, 2020
  • Last update: April 20, 2026
  • Version: 2026 narrative revision  

Editorial note: This article was originally published in the past and has been updated according to scientific and divulgative criteria. The purpose is informative: it does not replace medical or specialist advice. In case of doubts about symptoms, therapies, or integrations, consult a doctor.

IN BRIEF

  • Vitamin D is a pro-hormone important for bone metabolism and has documented roles in modulating the immune system.
  • Low levels of 25-hydroxyvitamin D are associated with a higher risk of respiratory infections and some chronic diseases in observational analyses.
  • Clinical studies on supplementation to prevent chronic diseases yield mixed results; greater benefits have been observed in severely deficient individuals.
  • Common signs of possible deficiency include muscle weakness, bone pain, conditions that reduce absorption or sun exposure, obesity, very dark skin, and behavioral anhedonia.
  • The decision on blood tests and supplementation should be personalized and discussed with a healthcare professional.

Abstract: what does science say?

Vitamin D (measured as 25-hydroxyvitamin D in the blood) is essential for skeletal health and is involved in cellular processes that modulate inflammation and immune response. Observational evidence associating low vitamin D levels with infections, some autoimmune diseases, and increased mortality is numerous, but does not necessarily determine causality. Randomized controlled trials (RCTs) and meta-analyses show that supplementation produces clear benefits, especially in subjects with severe deficiency, while in non-deficient populations, the results are frequently null or modest. The effect depends on the baseline level of 25(OH)D, dose, duration, method of administration, and co-supplementation (e.g., calcium). Practical recommendations emphasize the importance of assessing individual risk and preferring a personalized diagnostic-therapeutic approach.

What is vitamin D for and where to find it

Vitamin D acts as a precursor to steroid hormones that regulate calcium metabolism and bone mineralization, functions long known. It is also involved in numerous cellular processes in tissues other than bone, thanks to the presence of the vitamin D receptor in many cells. This dual identity — nutrient/hormone precursor and local cellular modulation factor — explains the interest in its possible extra-skeletal effects.[1]

The main production pathway is cutaneous, through tissue exposure to UVB radiation; to a lesser extent, vitamin D is taken in with certain foods: fatty fish, cod liver oil, egg yolks, some fortified dairy products, and sun-exposed mushrooms. The circulating form most used to assess nutritional status is 25-hydroxyvitamin D (25[OH]D).[1]

From a biological point of view, immune system cells express the enzymes necessary to convert the circulating form into the locally active form, allowing modulating effects on innate and adaptive responses; this provides biological plausibility for the impact of vitamin D on immunity, although it does not in itself demonstrate clear clinical effects in all conditions.[2]

Deficiency and main consequences

Severe vitamin D deficiency is a known cause of rickets in children and osteomalacia in adults; suboptimal levels compromise bone mineralization and increase the risk of skeletal fragility. Beyond skeletal manifestations, low 25(OH)D values have been associated in observational studies with a higher incidence of respiratory infections, some autoimmune diseases, and an increase in mortality in the analyzed cohorts; however, the results of clinical interventions are variable and depend on the context and the degree of initial deficiency.[1][3]

The main signs of deficiency

  • Muscle weakness and widespread bone pain;
  • Fatigue and symptoms of low mood or depression (observational, non-causal association);
  • Excessive head sweating (observed but non-specific clinical sign);
  • History of intestinal malabsorption (Crohn's disease, celiac disease) or digestive surgeries that reduce lipid absorption;
  • Obesity or high adipose mass, which reduce the blood availability of fat-soluble vitamin D;
  • Dark skin or limited sun exposure (hypopigmentation favors cutaneous synthesis, pigmentation can reduce it);
  • Chronic use of certain drugs or substance abuse that interfere with vitamin metabolism (evaluate case by case).

What it means in practice

For the general population, the practical strategy focuses on preventing severe cases: ensuring adequate safe sun exposure, a diet that contains vitamin D sources, and evaluating at-risk groups for blood tests. In cases with risk factors (advanced age, malabsorption, obesity, very dark skin, use of interfering drugs, poor sun exposure), the doctor may request a 25-hydroxyvitamin D dosage and decide on any targeted treatment.[1][7]

Reviews of clinical studies show that supplementation reduces the incidence of respiratory infections, especially in subjects with very low baseline 25(OH)D values; the effect is less evident when vitamin D is administered to non-deficient individuals.[3] On the other hand, large trials in general populations have not shown clear reductions in cardiovascular events or cancer incidence with routine supplementation.[5]

In practice: indiscriminate supplementation for the prevention of chronic diseases is not recommended; the effective choice is to test and treat cases with documented deficiency or high risks. Doses, duration, and monitoring must be decided by a professional based on the initial level, age, and individual clinical conditions.[6]

Key points to remember

  1. Vitamin D is crucial for bones and modulates immune responses at the cellular level.
  2. Observational associations with diseases do not always imply causality: they are often influenced by habits, clinical conditions, and confounders.
  3. Benefits of supplementation are more likely in people with documented severe hypovitaminosis.
  4. Diagnostic tests (25[OH]D) are useful for personalized decisions; they are not necessary for everyone.
  5. Obesity, malabsorption, dark skin, and poor sun exposure increase the risk of insufficient levels.

Limitations of evidence

It is important to differentiate between study types: observational studies identify associations between vitamin D levels and health outcomes but do not prove causality, as they can be influenced by confounding factors (e.g., lifestyle, comorbidities). Causal evidence is primarily provided by RCTs and genetic Mendelian randomization studies; the latter can support or exclude causal hypotheses when well-designed.[8]

Meta-analyses and large RCTs show mixed results: some reviews indicate a reduction in respiratory infections in deficient people receiving supplementation,[3] while other works on unselected populations have not found clear benefits on fractures, cardiovascular events, or cancer incidence.[6][5] Differences emerge depending on the baseline level, dose, frequency of administration (bolus vs daily), duration, and co-administration of calcium.

Other limitations include the variability of laboratory methods for 25(OH)D, ethnic and geographical differences, and the effect of conditions such as obesity that modify vitamin D pharmacokinetics, reducing its blood availability.[7] Mendelian randomization studies have suggested associations with mortality, but do not unequivocally support the generalization of supplementation to the entire population.[8]

Editorial conclusion

Vitamin D remains an essential element for skeletal health and has a plausible modulating action on the immune system. Current evidence indicates that supplementation is most useful when targeted at those with a demonstrated deficiency or clear risk factors. For the general population, simple preventive strategies (prudent sun exposure, diet with adequate sources, and attention to vulnerable groups) are recommended. Clinical decisions — diagnostic tests, doses, and duration of treatment — must be individualized and based on medical evaluation. Areas of uncertainty remain that justify further specific studies on dosage, at-risk populations, and relevant clinical outcomes.

Editorial note

This update has been drafted with criteria of scientific rigor and divulgative language. The article summarizes published evidence and does not replace a medical visit. For therapeutic or diagnostic decisions, consult your doctor.

SCIENTIFIC RESEARCH

  1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. https://doi.org/10.1056/NEJMra070553
  2. Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–886. https://doi.org/10.2310/JIM.0b013e31821b8755
  3. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. https://doi.org/10.1136/bmj.i6583
  4. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection. Arch Intern Med. 2009;169(4):384–390. https://doi.org/10.1001/archinternmed.2008.560
  5. Manson JE, Cook NR, Lee IM, et al.; VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44. https://doi.org/10.1056/NEJMoa1809944
  6. Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6(11):847–858. https://doi.org/10.1016/S2213-8587(18)30265-1
  7. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–693. https://doi.org/10.1093/ajcn/72.3.690
  8. Afzal S, Brøndum-Jacobsen P, Bojesen SE, Nordestgaard BG. Genetically low vitamin D concentrations and increased mortality: mendelian randomisation analysis in three large cohorts. BMJ. 2014;349:g6330. https://doi.org/10.1136/bmj.g6330

Selected sources and citations: see list above for access to original documents. Research has been verified for DOI and relevance to the topic.